(Q24645548)
Statements
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer (English)
0 references
1 September 2009
0 references
27
0 references
25
0 references
4116-23
0 references
1 reference
1 reference
1 reference
1 reference
1 reference